The EndoBarrierTM Gastrointestinal Liner is a breakthrough treatment designed to help patients regain metabolic control of Type 2 Diabetes and to aid in weight loss.
It is a new class of treatment that fits between pharmaceutical regimens and surgery. It is performed easily and quickly without any incisions and just a few hours in hospital.
Based on the growing body of clinical evidence, EndoBarrierTM has the potential to dramatically change the treatment approach for people who are obese or have Type 2 Diabetes. Clinical experience has found that EndoBarrierTM can provide immediate relief from Type 2 Diabetes in patients with significantly elevated HbA1c.
In addition, most patients experience clinically significant weight loss. This is believed to have a long term effect in managing insulin resistance as well as a positive impact on cardiovascular risk factors, including elevated lipid levels and high blood pressure.